Correlation between Polymorphism of TRAIL Gene and Condition of Intervertebral Disc Degeneration.

Item

http://www.wikidata.org/entity/Q35939523

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Correlation between Polymorphi ...... ervertebral Disc Degeneration.

@ast

Correlation between Polymorphi ...... ervertebral Disc Degeneration.

@en

type

Item

label

Correlation between Polymorphi ...... ervertebral Disc Degeneration.

@ast

Correlation between Polymorphi ...... ervertebral Disc Degeneration.

@en

prefLabel

Correlation between Polymorphi ...... ervertebral Disc Degeneration.

@ast

Correlation between Polymorphi ...... ervertebral Disc Degeneration.

@en

P1476

Correlation between Polymorphi ...... ervertebral Disc Degeneration.

@en

P2093

Shimin Xu

http://www.w3.org/2001/XMLSchema#string

Shuzhong Li

http://www.w3.org/2001/XMLSchema#string

Ting Liang

http://www.w3.org/2001/XMLSchema#string

P2860

Methionine Deprivation Induces a Targetable Vulnerability in Triple-Negative Breast Cancer Cells by Enhancing TRAIL Receptor-2 Expression

An Lnc RNA (GAS5)/SnoRNA-derived piRNA induces activation of TRAIL gene by site-specifically recruiting MLL/COMPASS-like complexes.

Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells.

C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity

Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells.

Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11.

Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatme

The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.

TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells.

Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels.

P304

2282-2287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.894157

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26245704

http://www.w3.org/2001/XMLSchema#string

P932

4532195

http://www.w3.org/2001/XMLSchema#string